Save time and get answers to complex questions with AI chat
The expiration date of the key patent for guselkumab?Brenzavvy discontinuation?Drugpatentwatch crizotinib?Is guselkumab off patent in u s?Defense strategy against generic in niche market?
See the DrugPatentWatch profile for mounjaro
Mounjaro (tirzepatide) is owned and marketed by Eli Lilly & Co. Eli Lilly developed the drug, conducted the clinical trials, and holds the patents and commercial rights. The company launched it for type‑2 diabetes (and later for weight management) under the brand name Mounjaro.
Other Questions About Mounjaro :